Cover Image
市場調查報告書

神經調節療法用設備:全球產業及市場

Neuromodulation Devices 2016-2026: Revenue Forecasts for Deep Brain Stimulation, Spinal Cord, Vagus Nerve, Sacral Nerve and Gastric Electrical Applications

出版商 Visiongain Ltd 商品編碼 224394
出版日期 內容資訊 英文 200 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經調節療法用設備:全球產業及市場 Neuromodulation Devices 2016-2026: Revenue Forecasts for Deep Brain Stimulation, Spinal Cord, Vagus Nerve, Sacral Nerve and Gastric Electrical Applications
出版日期: 2016年03月14日 內容資訊: 英文 200 Pages
簡介

本報告以全球神經調節療法用設備市場為主題,提供最新的各市場趨勢分析,全球、地區、次市場(脊髓電刺激:SCS、腦深部刺激:DBS、腸胃電刺激:GES、迷走神經刺激:VNS設備、SNS薦椎神經刺激的各療法)的市場預測,市場SWOT分析及新產業機會相關分析等彙整,為您概述為以下內容。

第1章 調查概要

第2章 神經調節的簡介

  • 神經調節
  • 神經調節所使用的技術
    • 電刺激療法
    • 藥物療法
  • 神經調節應用
    • 疼痛
    • 憂鬱症
    • 癲癇
    • 便、尿失禁
    • 聽覺障礙:高度聽障
    • 心臟疾病:心律不整及心絞痛
    • 神經退化性疾病:帕金森氏症

第3章 全球神經調節療法用設備市場

  • 全球神經調節療法用設備市場
  • 全球神經調節療法用設備市場預測
  • 神經調節療法用設備:產業趨勢

第4章 脊髓電刺激療法(SCS)市場

  • 市場概要
  • 市場預測
  • 最很暢銷的治療設備
  • 治療方法的適用
  • 市場趨勢

第5章 腦深部刺激療法(DBS)

第6章 腸胃電刺激療法(GES)

第7章 迷走神經刺激療法(VNS)

第8章 薦椎神經刺激療法(SNS)

第9章 其他神經調節療法技術

第10章 主要先進國家市場

  • 神經調節療法用設備:主要先進國家市場
  • 美國市場
  • 日本市場
  • 德國市場
  • 法國市場
  • 義大利市場
  • 英國市場
  • 西班牙市場

第11章 主要新興國家市場

  • 神經調節療法用設備:主要新興國家市場
  • 巴西市場
  • 中國市場
  • 印度市場
  • 俄羅斯市場

第12章 神經調節治療用設備市場:廠商

  • Medtronic
    • 銷售額、近幾年的業績分析
    • 國際產業
    • 神經調節治療設備產業的實際成果
    • 新聞
    • 市場展望
  • Boston Scientific
  • St. Jude Medical (SJM)
  • Cyberonics
  • 其他的企業
    • Stryker Corporation
    • Nevro Corp.
    • SetPoint Medical
    • Functional Neuromodulation
    • Neurotherapies Reset
    • Wiringless Implantable Stretchable Electronics (WISE)
    • SceneRay
    • Mindray

第13章 神經調節治療用設備市場定性分析

  • SWOT分析
  • STEP分析

第14章 專家的見解(採訪調查)

第15章 結論

  • 美國:依然最大的各國市場
  • 神經調節發病的增加
  • 老年人口的增加促進市場成長
  • 中國及印度新興引導市場的預定
  • DBS及VNS:市場未來
  • 結論

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0098

Neuromodulation devices - your 2016 guide to trends, opportunities and future revenues

Discover the future of medical devices to stimulate and treat the central nervous system. Neuromodulation devices hold high, rising sales potential. Now you can explore forecasts and see predicted revenues. Assess the expected gains.

Visiongain's updated report predicts those revenues to 2026 at overall world market, submarket and national level. With our new survey you stay ahead in that CNS data and analysis, discovering medical, technological and commercial opportunities and prospects.

With that study you explore what the future holds for those companies. Read on now to investigate neuronal devices, also seeing a revenue prediction below.

Forecasts and other analyses to help your research, knowledge and influence

Do you struggle to find business data on neuromodulation and neurostimulation therapies? Instead today discover potentials of those treatments for brain and other nervous system disorders. Our report analyses the future of that healthcare industry, showing potential gains.

With that updated study make your research, analyses and plans easier and quicker. That way you can also benefit your reputation for commercial insight. See what is possible.

In addition to multilevel forecasting to 2026, our new study shows you results, growth rates, market shares, opinions and discussions. In that report you gain 65 charts, 30 tables and interviews with two organisations. Our work's purpose is to help you stay ahead.

There discover how competition and technological advances shape that industry. Also benefit your knowledge and authority. See what sales are possible from 2016 in the neuromodulators industry and investigate how you can gain. Sections below explain.

Forecasting of that world market and its segments - what is possible?

Our study predicts overall world revenue to 2026 for neuromodulating and neurostimulating technologies.

There, in our work, you also find individual revenue predictions to 2026 for six submarkets at world level:

  • Spinal cord stimulation (SCS)
  • Deep brain stimulation (DBS)
  • Vagus/vagal nerve stimulation (VNS)
  • Sacral nerve stimulation (SNS)
  • Gastric electrical stimulation (GES)
  • Other techniques (grouped forecast), including trigeminal nerve stimulation, cochlear implants, transcranial magnetic stimulation, transcranial direct current stimulation and ultrasonic neuromodulation.

With that analysis you investigate the most promising and lucrative parts of the neuromodulators industry. See how it can progress. Our study predicts high, rising sales. You explore where, when, how and why market expansion can occur.

Our investigation also splits its overall world market into geographical revenue predictions.

National markets - what outlooks for neuromodulators' sales?

Our analyses also show you individual revenue forecasts to 2026 for 11 countries:

  • United States
  • Japan
  • Germany, France, United Kingdom, Italy and Spain (EU5 group)
  • Brazil, Russia, India and China (BRIC countries).

Healthcare developments worldwide stimulate that industry's revenues. With our data you find countries with highest revenues, demand and potential sales. See needs and opportunities. And explore the expected trends, progress and gains.

So how do changes, challenges and technological advances affect that industry and market?

image2

Forces, events and issues influencing that medical devices field

Our updated report explains policies, trends and R&D shaping that industry and market, including these developments:

  • Widening applications in treating pain, depression, epilepsy, incontinence, hearing disorders, heart conditions and neurodegenerative diseases, inc. Parkinson's
  • Market trends - ageing populations raising demand, personalised healthcare, regulations and changes in that medical devices segment
  • Emerging technology - cochlear implants, transmagnetic stimulation (TMS), transcranial direct current stimulation (tDCS) and ultrasonic applications.

With that work you assess the industry's strengths, weaknesses, opportunities and threats, also exploring social, technological, economic and political questions. Those analyses help you assess what stimulates and restrains companies. Explore what the future holds.

Neuromodulation technology - leading companies and 2020 market value

What happens next? From 2016 neuromedical devices hold great potential for investments, medical advances and sales. Our report predicts the world market for those products will reach $9.3bn in 2020, with fast 2016-2026 sales growth. High potentials exist for companies.

In particular our study discusses performances, activities and potentials of four leading organisations:

  • Medtronic
  • Boston Scientific
  • St. Jude Medical
  • Cyberonics.

Discussions of rising companies appear too. The survey also shows visiongain's interviews with the International Neuromodulation Society and NeuroSigma.

With our analysis you see how that market can develop and perform from 2016, benefiting your insight and authority. See there how you can benefit your research and analysis.

7 ways Neuromodulation Devices 2016-2026 helps you stay ahead of competitors

Our new study benefits your decisions, plans and proposals in these seven main ways:

  • Revenue to 2026 for the worldwide neuromodulation devices industry - discover its overall potential
  • Predictions to 2026 for 6 submarkets - investigate product categories at world level, finding the most lucrative and promising opportunities
  • Forecasts to 2026 for 11 national markets in the Americas, Europe and Asia - discover the best regions and countries for revenue expansion
  • Activities of established and rising companies - hear about firms' products, capabilities, advances and outlooks, seeing what is possible
  • Technological developments - investigate R&D progress, exploring technological, clinical and commercial opportunities, seeing what is happening and possible
  • Interviews with other authorities - discover what organisations there say and do, helping you stay ahead in knowledge
  • Analysis of what stimulates and restrains that market - assess challenges and strengths, helping you compete and succeed.

In our investigation you find independent business analysis by visiongain's UK-based team. Gain data found only there, information to help your research, analysis and presentations.

That way you can benefit your authority and reputation for insight. Stay ahead in knowledge.

Trying our analysis now lets you discover sales trends, opportunities and predictions

Our independent study shows you data, trends, opportunities and forecasts for neuromodulation therapy. Please avoid missing out. Instead get our new report here now.

Table of Contents

1. Report Overview

  • 1.1 Overview of the World Market for Neuromodulation Devices
  • 1.2 Why You Should Read This Report
  • 1.3 How this Report Delivers
  • 1.4 Main Questions Answered by this Analysis
  • 1.5 Who is this Report For?
  • 1.6 Methodology
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to Neuromodulation

  • 2.1 Neuromodulation
  • 2.2 Techniques Used in Neuromodulation
    • 2.2.1 Electrical Stimulation Techniques
      • 2.2.1.1 Brain and Spinal Cord Therapies
      • 2.2.1.2 Cranial Nerve Stimulation
      • 2.2.1.3 Functional Electrical Stimulation
    • 2.2.2 Pharmacological Therapy
  • 2.3 Application of Neuromodulation
    • 2.3.1 Pain
    • 2.3.2 Depression
    • 2.3.3 Epilepsy
    • 2.3.4 Faecal and Urinary Incontinence
    • 2.3.5 Hearing Disorders - Profound Deafness
    • 2.3.6 Cardiovascular Diseases - Arrhythmia and Angina
    • 2.3.7 Neurodegenerative Diseases - Parkinson's Disease

3. The Global Neuromodulation Devices Market, 2016-2026

  • 3.1 Global Neuromodulation Devices Market: 2015
  • 3.2 Global Neuromodulation Devices Forecast: 2015-2026
  • 3.3 Neuromodulation Devices: Industry Trends, 2016-2026
    • 3.3.1 Industry Trends - Ageing Population
    • 3.3.2 Rising Prevalence of Chronic Diseases
    • 3.3.3 Industry Trends - Personalised Healthcare
    • 3.3.4 Industry Trends - National Regulations
    • 3.3.5 Political Uncertainty and Security Risk across the World
    • 3.3.6 Industry Trends - Economic Challenges
    • 3.3.7 Industry Trends - Mergers and Acquisitions

4. Spinal Cord Stimulation Submarket, 2016-2026

  • 4.1 Spinal Cord Stimulation (SCS) Market Overview, 2015
  • 4.2 SCS Market Forecast: 2015-2026
  • 4.3 Top Selling SCS Devices, 2016
  • 4.4 Applications of Spinal Cord Stimulation
  • 4.5 SCS Market Trends: 2016-2026

5. Deep Brain Stimulation Submarket, 2016-2026

  • 5.1 Deep Brain Stimulation (DBS) Market Overview, 2015
  • 5.2 DBS Market Forecast: 2015-2026
  • 5.3 Top Selling DBS Devices, 2016
  • 5.4 Applications of Deep Brain Stimulation
  • 5.5 DBS Market Trends: 2016-2026

6. Gastric Electrical Stimulation Submarket, 2016-2026

  • 6.1 Gastric Electrical Stimulation (GES) Market Overview, 2015
  • 6.2 GES Market Forecast: 2015-2026
  • 6.3 Top Selling GES Devices, 2016
  • 6.4 Applications of Gastric Electrical Stimulation
  • 6.5 GES Market Trends: 2016-2026

7. Vagus Nerve Stimulation Submarket, 2016-2026

  • 7.1 Vagus Nerve Stimulation (VNS) Market Overview, 2015
  • 7.2 VNS Market Forecast: 2015-2026
  • 7.3 Top Selling VNS Devices, 2016
  • 7.4 Applications of Vagus Nerve Stimulation
  • 7.5 VNS Market Trends: 2016-2026

8. Sacral Nerve Stimulation Submarket, 2016-2026

  • 8.1 Sacral Nerve Stimulation (SNS) Market Overview, 2015
  • 8.2 SNS Market Forecast: 2016-2026
  • 8.3 Top Selling SNS Devices; 2016
  • 8.4 Applications of Sacral Nerve Stimulation
  • 8.5 SNS Market Trends: 2016-2026

9. Other Neuromodulation Technologies Submarket, 2016-2026

  • 9.1 Other Neuromodulation Technologies Overview, 2015
    • 9.1.1 Trigeminal Nerve Stimulation
    • 9.1.2 Cochlear Implants
    • 9.1.3 Transcranial Magnetic Stimulation (TMS)
    • 9.1.4 Transcranial Direct Current Stimulation (tDCS)
    • 9.1.5 Ultrasonic Neuromodulation
  • 9.2 Other Neuromodulation Techniques Forecast: 2015-2026

10. Neuromodulation Devices in Leading National Developed Markets, 2016-2026

  • 10.1 Neuromodulation Devices: Leading Developed Markets, 2015
  • 10.2 The US Neuromodulation Devices Market: 2016-2026
    • 10.2.1 The US Neuromodulation Devices Market: 2015
    • 10.2.2 The US Neuromodulation Devices Market Forecast: 2015-2026
  • 10.3 The Japanese Neuromodulation Devices Market: 2016-2026
    • 10.3.1 The Japanese Neuromodulation Devices Market: 2015
    • 10.3.2 The Japanese Neuromodulation Devices Market Forecast: 2015-2026
    • 10.3.3 The Effects of Regulations on the Japanese Market
  • 10.4 The German Neuromodulation Devices Market: 2016-2026
    • 10.4.1 The German Neuromodulation Devices Market: 2015
    • 10.4.2 The German Neuromodulation Devices Market Forecast: 2015-2026
  • 10.5 The French Neuromodulation Devices Market: 2016-2026
    • 10.5.1 The French Neuromodulation Devices Market: 2015
    • 10.5.2 The French Neuromodulation Devices Market Forecast: 2015-2026
    • 10.5.3 The French Neuromodulation Devices Market - the Economy and its Implications
  • 10.6 The Italian Neuromodulation Devices Market: 2016-2026
    • 10.6.1 The Italian Neuromodulation Devices Market: 2015
    • 10.6.2 The Italian Neuromodulation Devices Market Forecast: 2015-2026
    • 10.6.3 The Italian Neuromodulation Devices Market Outlook
  • 10.7 The UK Neuromodulation Devices Market: 2016-2026
    • 10.7.1 The UK Neuromodulation Devices Market: 2015
    • 10.7.2 The UK Neuromodulation Devices Market Forecast: 2015-2026
    • 10.7.3 The UK Neuromodulation Devices Market Forecast - Political Challenges
  • 10.8 The Spanish Neuromodulation Devices Market: 2016-2026
    • 10.8.1 The Spanish Neuromodulation Devices Market: 2015
    • 10.8.2 The Spanish Neuromodulation Devices Market Forecast: 2015-2026
    • 10.8.3 The Spanish Neuromodulation Devices Outlook

11. Neuromodulation Devices in Leading Emerging Markets, 2016-2026

  • 11.1 Neuromodulation Devices: Leading Emerging Markets, 2015
  • 11.2 The Brazilian Neuromodulation Devices Market: 2016-2026
    • 11.2.1 The Brazilian Neuromodulation Devices Market: 2015
    • 11.2.2 The Brazilian Neuromodulation Device Market Forecast: 2015-2026
    • 11.2.3 The Brazilian Neuromodulation Devices Market: Economic and Political Challenges Affecting Prospects
  • 11.3 The Chinese Neuromodulation Devices Market: 2016-2026
    • 11.3.1 The Chinese Neuromodulation Devices Market: 2015
    • 11.3.2 The Chinese Neuromodulation Devices Market Forecast: 2015-2026
    • 11.3.3 The Chinese Neuromodulation Devices Market: Amendments to Regulations.
  • 11.4 The Indian Neuromodulation Devices Market: 2016-2026
    • 11.4.1 The Indian Neuromodulation Devices Market: 2015
    • 11.4.2 The Indian Neuromodulation Devices Market Forecast: 2015-2026
    • 11.4.3 The Indian Neuromodulation Devices Market: What's Possible in that Rising Industrial Power?
  • 11.5 The Russian Neuromodulation Devices Market: 2016-2026
    • 11.5.1 The Russian Neuromodulation Devices Market: 2015
    • 11.5.2 The Russian Neuromodulation Devices Market Forecast: 2015-2026

12. Neuromodulation Devices Market: Manufacturers

  • 12.1 Medtronic
    • 12.1.1 Sales and Recent Performance Analysis: 2015
    • 12.1.2 Medtronic International Operations
    • 12.1.3 Medtronic-Neuromodulation Performance
    • 12.1.4 Medtronic News
    • 12.1.4.1 Medtronic Mergers
    • 12.1.4.2 Expansion into DBS Market
    • 12.1.4.3 Medtronic Products
    • 12.1.5 Medtronic-Market Outlook
  • 12.2 Boston Scientific
    • 12.2.1 Sales and Recent Performance Analysis: 2015
    • 12.2.2 Boston Scientific International Operations
    • 12.2.3 Boston Scientific-Neuromodulation Performance
    • 12.2.4 Boston Scientific News
    • 12.2.4.1 Boston Scientific Acquisitions
    • 12.2.4.2 Expansion into DBS Market
    • 12.2.4.3 Boston Scientific Products
    • 12.2.5 Boston Scientific-Market Outlook
  • 12.3 St. Jude Medical (SJM)
    • 12.3.1 Sales and Recent Performance Analysis: 2015
    • 12.3.2 SJM International Operations
    • 12.3.3 SJM-Neuromodulation Performance
    • 12.3.4 SJM News
      • 12.3.4.1 SJM Acquisitions
      • 12.3.4.2 SJM Products
    • 12.3.5 SJM - Market Outlook
  • 12.4 Cyberonics
    • 12.4.1 Sales and Recent Performance Analysis: 2015
    • 12.4.2 Cyberonics International Operations
    • 12.4.3 Cyberonics - Neuromodulation Performance
    • 12.4.4 Cyberonics News
      • 12.4.4.1 Cyberonics Investments
      • 12.4.4.2 Cyberonics Products
    • 12.4.5 Cyberonics-Market Outlook
  • 12.5 Other Companies
    • 12.5.1 Stryker Corporation
    • 12.5.2 Nevro Corp.
    • 12.5.3 SetPoint Medical
    • 12.5.4 Functional Neuromodulation
    • 12.5.5 Neurotherapies Reset
    • 12.5.6 Wiringless Implantable Stretchable Electronics (WISE)
    • 12.5.7 SceneRay
    • 12.5.8 Mindray

13. Qualitative Analysis of the Neuromodulation Devices Market, 2016

  • 13.1 SWOT Analysis of the Neuromodulation Devices Market
    • 13.1.1 Strengths of the Market
      • 13.1.1.1 An Ageing Population
      • 13.1.1.2 Alternative Form of Treatment
      • 13.1.1.3 Convenience
      • 13.1.1.4 Long-term Effectiveness
    • 13.1.2 Weaknesses
      • 13.1.2.1 Research and Development (R&D)
      • 13.1.2.2 Oligarchic Market
      • 13.1.2.3 Adverse Side-Effects of Implantation
      • 13.1.2.4 Shortage of Trained Professionals
    • 13.1.3 Opportunities in the Neuromodulation Devices Market
      • 13.1.3.1 The Advancement of Research
      • 13.1.3.2 A Shift Towards Personalisation
      • 13.1.3.3 Expanding the Target Applications of the Devices
      • 13.1.3.4 Outsource Manufacturing of Devices
    • 13.1.4 Threats Facing the Neuromodulation Devices Market
      • 13.1.4.1 The Challenge of Regulation
  • 13.2 STEP Analysis of the Neuromodulation Devices Market
    • 13.2.1 Social Factors: The Role of Neuroethics
    • 13.2.2 Technological Developments: Drive towards Non-Invasive Methods
    • 13.2.3 Economic Restraints: High Production Costs
    • 13.2.4 Economic Potential: Emerging Markets Create Demand
    • 13.2.5 Political Issues: Strong Government Influence

14. Research Interviews

  • 14.1 Dr Timothy Deer, President, International Neuromodulation Society
    • 14.1.1 International Neuromodulation Society
    • 14.1.2 Landscape of the Current Neuromodulation Market
    • 14.1.3 Future Directions of the Neuromodulation Industry
  • 14.2 Dr Leon Ekchian, CEO, NeuroSigma, US
    • 14.2.1 NeuroSigma
    • 14.2.2 Understanding the Trigeminal Nerve Stimulation Therapy
    • 14.2.3 Challenges as a Neuromodulation Device Manufacturer
    • 14.2.4 Future Directions of the Neuromodulation Industry

15. Conclusions

  • 15.1 The United States Retains its Position as Market Leader
  • 15.2 Growing Incidences of Neurological Diseases
  • 15.3 Ageing Population Drives Growth
  • 15.4 China and India will Lead the Emerging Markets
  • 15.5 The Future of the Market - Deep Brain Stimulation and Vagus Nerve Stimulation
  • 15.6 Concluding Remarks

List of Tables

  • Table 1.1 Selected National Neuromodulation Devices Markets: Revenues ($m) and Market Shares (%) by Leading Country, 2014, 2020 and 2026
  • Table 3.1 Neuromodulation Devices Submarkets: Revenue ($bn), Annual Growth (%), CAGR (%), Market Share (%), 2014-2026
  • Table 3.2 Global Neuromodulation Devices Market: Revenue ($bn), Annual Growth (%), CAGRs (%), 2014-2026
  • Table 4.1 SCS Devices Forecast ($bn), Annual Growth (%), Market Share and CAGR (%), 2015-2026
  • Table 4.2 Leading SCS Devices, 2016
  • Table 5.1 The DBS Devices Forecast ($bn), Annual Growth (%), Market Share and CAGR (%), 2015-2026
  • Table 5.2 Leading DBS Devices, 2016
  • Table 6.1 The GES Devices Forecast ($bn), Annual Growth (%), Market Share and CAGR (%), 2015-2026
  • Table 6.2 Leading GES Devices, 2016
  • Table 7.1 The VNS Devices Forecast ($bn), Annual Growth, (%), Market Share and CAGR (%), 2015-2026
  • Table 7.2 Leading VNS Devices, 2016
  • Table 8.1 The SNS Devices Forecast ($bn), Annual Growth (%), Market Share and CAGR (%), 2015-2026
  • Table 8.2 Leading SNS Devices, 2016
  • Table 9.1 Other Neuromodulation Devices Market: Revenue Forecast ($bn), Annual Growth (%), Market Share and CAGR (%), 2015-2026
  • Table 10.1 Regional Neuromodulation Device Markets: Revenue ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2014-2026
  • Table 10.2 US Neuromodulation Devices: Revenue Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 10.3 Japanese Neuromodulation Devices Revenue Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 10.4 German Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 10.5 French Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 10.6 Italian Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 10.7 UK Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 10.8 Spanish Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 11.1 Neuromodulation Devices Emerging Markets: Revenue ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2014-2026
  • Table 11.2 Brazilian Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 11.3 Chinese Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 11.4 Indian Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 11.5 Russian Neuromodulation Devices Forecast ($bn), Annual Growth (%), Market Share (%) and CAGR (%), 2015-2026
  • Table 12.1 Medtronic Neuromodulation Revenue ($bn), 2012-2014
  • Table 12.2 Boston Scientific Neuromodulation Revenue ($bn), 2012-2014
  • Table 12.3 SJM Neuromodulation Revenue ($bn), 2012-2014
  • Table 12.4 Cyberonics Neuromodulation Revenue ($bn), 2011-2015

List of Figures

  • Figure 1.1 Neuromodulation Devices Market Segmentation, 2016
  • Figure 3.1 Global Neuromodulation Devices Market Share (%) Segmentation, 2015
  • Figure 3.2 Global Neuromodulation Devices Market: Revenue ($bn), AGR (%), 2014-2026
  • Figure 3.3 Global Neuromodulation Devices Market Share (%) Segmentation, 2026
  • Figure 3.4 Global Neuromodulation Devices Market: Drivers and Restraints, 2016-2026
  • Figure 4.1 SCS Devices Market Share (%) Segmentation, 2015
  • Figure 4.2 SCS Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 5.1 DBS Devices Market Share (%) Segmentation, 2015
  • Figure 5.2 DBS Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 6.1 GES Devices Market Share (%) Segmentation, 2015
  • Figure 6.2 GES Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 7.1 VNS Devices Market Share (%) Segmentation, 2015
  • Figure 7.2 VNS Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 8.1 SNS Devices Market Share (%) Segmentation, 2015
  • Figure 8.2 SNS Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 9.1 Other Neuromodulation Devices Market Share (%) Segmentation, 2015
  • Figure 9.2 Other Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 10.1 Regional Neuromodulation Devices Market Shares (%), 2015
  • Figure 10.2 Regional Neuromodulation Devices Market Shares (%), 2026
  • Figure 10.3 Developed National Markets: Drivers and Restraints, 2016-2026
  • Figure 10.4 The US Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 10.5 The Japanese Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 10.6 German Neuromodulation Devices Market Share (%) within the EU, 2015
  • Figure 10.7 The German Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 10.8 French Neuromodulation Devices Market Share (%) within the EU, 2015
  • Figure 10.9 The French Neuromodulation Device Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 10.10 Italian Neuromodulation Devices Market Share (%) within the EU, 2015
  • Figure 10.11 The Italian Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 10.12 UK Neuromodulation Devices Market Share (%) within the EU, 2015
  • Figure 10.13 The UK Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 10.14 Spanish Neuromodulation Devices Market Share (%) within the EU, 2015
  • Figure 10.15 Spanish Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 11.1 BRIC Neuromodulation Devices Market Shares (%), 2015
  • Figure 11.2 BRIC Neuromodulation Devices Market Shares (%), 2026
  • Figure 11.3 Emerging National Markets: Drivers and Restraints, 2016-2026
  • Figure 11.4 Brazilian Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 11.5 Chinese Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 11.6 Indian Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 11.7 Russian Neuromodulation Devices Revenue Forecast ($bn), AGR (%), 2015-2026
  • Figure 12.1 Medtronic Revenue ($bn), 2010-2015
  • Figure 12.2 Medtronic Operating Sectors (%), 2015
  • Figure 12.3 Medtronic Sales Shares (%), 2015
  • Figure 12.4 Medtronic Geographical Sales Shares (%), 2015
  • Figure 12.5 Medtronic Neuromodulation Revenue Shares (%) within Restorative Therapies, 2015
  • Figure 12.6 Medtronic Neuromodulation Revenue ($bn), 2012-2014
  • Figure 12.7 Boston Scientific Revenue ($bn), 2010-2014
  • Figure 12.8 Boston Scientific Operating Sectors (%), 2015
  • Figure 12.9 Boston Scientific Sector Shares (%), 2015
  • Figure 12.10 Boston Scientific World Sales Shares (%), 2015
  • Figure 12.11 Boston Scientific Geographical Sales Shares (%), 2015
  • Figure 12.12 Boston Scientific Neuromodulation Revenue ($bn), 2012-2014
  • Figure 12.13 Boston Scientific Neuromodulation Revenue Shares (%) within Med-Surgical Sector, 2015
  • Figure 12.14 St. Jude Medical Revenue ($bn), 2010-2014
  • Figure 12.15 St. Jude Medical Operating Sectors (%), 2015
  • Figure 12.16 St. Jude Medical World Sales Shares (%), 2014
  • Figure 12.17 St. Jude Medical Geographical Sales Shares (%), 2014
  • Figure 12.18 St. Jude Medical Revenue Distribution ($bn), 2013-2014
  • Figure 12.19 St. Jude Medical Sales Distribution ($bn), Q1 2014 to Q3 2014
  • Figure 12.20 St. Jude Medical Neuromodulation Revenue ($bn), 2012-2014
  • Figure 12.21 St. Jude Medical Neuromodulation Devices Quarterly Analysis ($bn), 2013-2014
  • Figure 12.22 Cyberonics Revenue ($bn), 2010-2015
  • Figure 12.23 Cyberonics World Sales Shares (%), 2015
  • Figure 12.24 Cyberonics Sales Distribution ($bn), 2013-2015
  • Figure 13.1 SWOT Analysis of the Neuromodulation Devices Market, 2016
  • Figure 13.2 STEP Analysis of the Neuromodulation Devices Market, 2016

Companies Listed

  • Accellent
  • Accuitive Medical Ventures (AMV)
  • Advanced Bionics
  • Advanced Neuromodulation Systems
  • Avery Biomedical
  • Axonics Modulation Technologies
  • Bard Electrophysiology
  • Bayer AG
  • Boston Scientific
  • Boston Scientific Innovation Centre (Shanghai, China)
  • Boston Scientific Institute for Advancing Science (Shanghai, China)
  • CardioMems
  • Cerbomed GmbH
  • CerebralRx
  • China Food and Drug Administration
  • Cirtec
  • Cochlear
  • Covidien
  • Cyberonics
  • Deep Brain Innovations
  • Department of Justice (US)
  • electroCore
  • European Commission
  • Foundation Medical Partners
  • Functional Neuromodulation
  • Genesys Capital
  • GlaxoSmithKline (GSK)
  • Halo Neuroscience
  • ImThera Medical
  • International Neuromodulation Society
  • IoGyn
  • Johnson & Johnson
  • Magstim
  • Mainstay Medical
  • Med-El
  • Medtronic
  • MetaCure
  • Mindray
  • Ministry of Health, Labour and Welfare (Japan)
  • Nanostim
  • National Health Service (UK)
  • National Institute for Health and Care Excellence (NICE, UK)
  • NDI Medical
  • NEA
  • NeuroSigma
  • NeuroStar
  • Neurotherapies Reset
  • NeuroTherm
  • Nevro Corp.
  • NOVO A/S
  • Pfizer
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • Roche
  • Sapiens Steering Brain Stimulation (Purchased by Medtronic)
  • SceneRay
  • SetPoint Medical
  • St. Jude Medical
  • StarMedTec
  • Stryker Corporation
  • Synova
  • Tyler Laboratory of Neuroscience and Neurotechnology
  • University of California, San Francisco
  • Uroplasty
  • US Food and Drug Administration (FDA)
  • Wiringless Implantable Stretchable Electronics (WISE)
Back to Top